Revelstoke Capital Partners has hired Eric A. Shuey as an operating partner. Previously, Shuey was a senior executive at Fresenius Medical Care. He is also on the board of directors of Encore Rehabilitation Services LLC, which is backed by Revelstoke.
Denver, CO (May 2, 2017) – Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, today announced it has expanded its team with the addition of Eric A. Shuey as an Operating Partner. Mr. Shuey is also on the board of directors of Encore Rehabilitation Services, LLC, a portfolio company of Revelstoke.
Eric A. Shuey has more than 25 years of private equity investing, corporate finance and executive management experience in the healthcare industry. Mr. Shuey previously served as a senior executive at Fresenius Medical Care where he was involved with various strategic initiatives, acquisitions and partnerships. Mr. Shuey was part of the senior management team of Liberty Dialysis Holdings, Inc. that grew Liberty into a leading national provider of dialysis services prior to its sale to Fresenius Medical Care AG in early 2012 for over $2.3 billion. He is an active investor, founder and board member of healthcare services businesses and has served on the boards of Apixio Inc.; MedeAnalytics; National Cardiovascular Partners; Partners Surgical, LLC; Remedy Partners; and Sound Physicians, Inc. Mr. Shuey previously served as a Director at DB Capital Partners, the private equity arm of Deutsche Bank responsible for over $10 billion in assets, and a Principal at Aurora Capital Group, a $1 billion private equity firm.
Mr. Shuey earned an MBA from the Wharton School of Business, where he was a Palmer Scholar. In addition, he has completed the coursework for a Ph.D. in Management at the Wharton School and earned his BA from California State University, Fullerton with highest honors.
“We are thrilled to have Eric as part of the Revelstoke team and we look forward to working closely with him to build value in our existing portfolio companies and to identify new and exciting investment opportunities.” said Simon Bachleda, Managing Partner at Revelstoke.
Revelstoke is a private equity firm focused on building industry-leading healthcare and business services companies. Revelstoke partners with entrepreneurs and management teams to execute on a disciplined organic and acquisition strategy to build exceptional companies. Revelstoke has ~$1.0 billion of assets under management and has completed 31 acquisitions which includes 8 platform companies and 23 add on acquisitions, totaling $1.4 billion in enterprise value.